Initial trials of low-dose lithium failed to improve long COVID symptoms, but new findings suggest higher doses could offer hope for patients suffering from fatigue and cognitive impairment. Study: ...

A small UB clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; however, a supplemental ...

In subsequent dose-finding study, numerically greater reductions seen in fatigue, cognitive dysfunction scores with 40 to 45mg/day. HealthDay News — Lithium aspartate is not effective for neurologic ...

Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed.

Add Yahoo as a preferred source to see more of our stories on Google. A small dose of the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long COVID, but a larger ...

A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; ...

A small dose of the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long COVID, a small, new trial involving 52 patients has found. Still, it's possible that a larger ...

BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of ...

A small clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID. A small University at ...

THURSDAY, Oct. 3, 22024 (HealthDay News) -- A small dose of the nutritional supplement lithium asparate may not ease the fatigue and brain fog of Long COVID, a small, new trial involving 52 patients ...